Abstract
Cancer patients are simultaneously at an increased risk of venous thromboembolic complications and a high risk of bleeding. The decision to conduct thromboprophylaxis in oncology patients should be based on an assessment of the individual risk of thrombosis and major bleeding.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
